Response

Affiliations

¹ All India Institute of Medical Sciences, New Delhi, Delhi, India.
² All India Institute of Medical Sciences, New Delhi, Delhi, India. Electronic address: prakash41@aiims.edu.

Comment

Bharath Gopinath et al. Chest. 2023 Nov.

. 2023 Nov;164(5):e160.

doi: 10.1016/j.chest.2023.07.005. Epub 2023 Nov 7.

¹ All India Institute of Medical Sciences, New Delhi, Delhi, India.
² All India Institute of Medical Sciences, New Delhi, Delhi, India. Electronic address: prakash41@aiims.edu.

No abstract available

Conflict of interest statement

Financial/Nonfinancial Disclosures See earlier cited article for author conflicts of interest.

Nebulized vs IV Tranexamic Acid for Hemoptysis: A Pilot Randomized Controlled Trial.
Gopinath B, Mishra PR, Aggarwal P, Nayaka R, Naik SR, Kappagantu V, Shrimal P, Ramaswami A, Bhoi S, Jamshed N, Sinha TP, Ekka M, Kumar A. Gopinath B, et al. Chest. 2023 May;163(5):1176-1184. doi: 10.1016/j.chest.2022.11.021. Epub 2022 Nov 19. Chest. 2023. PMID: 36410494 Clinical Trial.
IV or Nebulized Tranexamic Acid for Hemoptysis: Can We Stop There?
Cazes N, Briquet A, Delcasso B. Cazes N, et al. Chest. 2023 Nov;164(5):e159. doi: 10.1016/j.chest.2023.06.044. Epub 2023 Nov 7. Chest. 2023. PMID: 37945203 No abstract available.